Structural and regulatory pathway interaction
Here's why: Scientific Backing: L-carnitine is supported by numerous studies demonstrating its efficacy in muscle recovery and reducing muscle soreness
Thioredoxin reductase - its role in epidermal redox status
Ideal candidates for leading with NAD+: Patients over 40 experiencing persistent fatigue that does not resolve with sleep or lifestyle changes Individuals with metabolic syndrome, insulin resistance, or difficulty managing weight despite dietary effort Patients recovering from substance use, where NAD+ IV therapy has shown measurable benefit in reducing withdrawal symptoms and cravings High-performance athletes or executives seeking cognitive edge and faster physical recovery Patients with early neurodegenerative concerns who want evidence-supported mitochondrial support GHK-Cu Dosage and NAD+ Dosage: What Clinical Protocols Actually Use Dosing varies based on delivery route, patient body weight, and clinical goal
Malabsorption Issues: Conditions like Crohn's disease, celiac disease, or previous gastric surgery can interfere with B12 absorption from food
T cells and reactive oxygen species
